Hematology NewsIdelalisib shows long-term safety, efficacy for relapsed CLLApril 26, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaRare Diseases
Hematology NewsTagraxofusp produces high response rate in BPDCNApril 24, 2019Leukemia, Myelodysplasia, TransplantationALLRare Diseases
Hematology NewsComplementary medicine use common among patients on TKIsApril 24, 2019CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesModel inspired by Netflix, Amazon may help guide MDS treatmentApril 23, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
Hematology TimesSorafenib plus GCLAM held safe in AML, MDS phase-1 studyApril 22, 2019Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesStudy highlights lack of data on transgender leukemia patientsApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology TimesALF 2019 showcases evolving treatment of AMLApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationTransplantationTransplant
Hematology TimesBack to the drawing board for MPN comboApril 18, 2019Leukemia, Myelodysplasia, TransplantationCythemiasAML
Hematology TimesCreating CAR T-cell therapies for T-cell malignanciesApril 16, 2019ALLT Cell LymphomasLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapyCellular TherapyImmuno-oncology
Hospital Physician: Hematology/OncologyManagement of Early Pulmonary Complications After Hematopoietic Stem Cell TransplantationApril 15, 2019Leukemia, Myelodysplasia, Transplantation
Hematology NewsGilteritinib prolonged survival in FLT3-mutated AMLApril 12, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsBendamustine/rituximab combo proves viable for comorbid CLLApril 10, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaRare Diseases
Hematology NewsWhole-genome sequencing demonstrates clinical relevanceApril 4, 2019AMLALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib sustained responses in refractory CLL in long-term follow-upMarch 27, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsVenetoclax and obinutuzumab induces deep responses in CLLMarch 18, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
